Neffy: The Innovative Solution Transforming Anaphylaxis Treatment

neffy nasal spray for anaphylaxis, neffy epinephrine for severe allergic reactions, needle-free epinephrine

Epinephrine, the first-line treatment for anaphylaxis, has traditionally been available in auto-injectors like EpiPens. Last month, the Food and Drug Administration (FDA) approved Neffy, the first needle-free epinephrine product for treating life-threatening allergic reactions (anaphylaxis).

Understanding Neffy: The First Epinephrine Nasal Spray

Anaphylaxis is a severe allergic reaction that requires immediate attention and epinephrine administration. Neffy epinephrine nasal spray is a revolutionary new solution for managing life-threatening allergic reactions, such as anaphylaxis. Needle-free epinephrine with Neffy nasal spray delivers a life-saving dose of epinephrine through the nasal passage. This product, developed by ARS Pharmaceuticals, aims to eliminate the need for needle injectors like EpiPens, which are used to counteract severe allergic reactions.

Neffy provides those at risk of anaphylaxis and with severe allergies a needle-free alternative for managing and treating their life-threatening conditions. Epinephrine auto-injectors can be intimidating or challenging to use in times of emergency, but Neffy provides an easy-to-administer solution for patients, families, and healthcare providers.

How Does Neffy Nasal Spray Work?

Mild and severe allergic reactions can manifest through several symptoms, including hives, itchy skin or eyes, low blood pressure, and swelling of the throat, tongue, and face. Epinephrine plays a significant role in the body’s acute stress response, acting on alpha and beta-adrenergic receptors to stimulate the sympathetic nervous system. Neffy nasal spray delivers epinephrine through the nasal passage, which allows rapid absorption into the bloodstream.

When epinephrine is sprayed into the nostril, it absorbs within minutes to reverse the adverse symptoms of anaphylaxis. Neffy’s epinephrine absorption is comparable to standard intramuscular injections, making it an equally effective treatment, if not more effective. Individuals with severe allergies to foods, medications, insect stings or bites, latex, etc., now have another treatment method for their life-threatening condition.

How Much Does Neffy Cost?

Neffy epinephrine nasal spray will be available for those with commercial insurance as low as $25 per prescription. For patients without commercial insurance or a plan that covers Neffy, ARS Pharmaceuticals is offering a Neffy prescription for $199 through a digital pharmacy known as BlinkRX. This cash price is also available through GoodRx.

Neffy is intended to be affordable and accessible to everyone who needs it. When epinephrine products are too expensive, this raises the risk of life-threatening anaphylaxis. Due to high prescription costs, individuals with severe allergies will contemplate administering epinephrine in times of need, which should never be the case.

The Benefits of Using Neffy for Severe Allergic Reactions

Neffy is a groundbreaking innovation in treating type 1 allergic reactions like anaphylaxis. 1 in every 20 Americans are at risk of life-threatening anaphylaxis, which is over 15 million adults and children. Neffy offers millions of individuals a new, user-friendly alternative that makes managing anaphylaxis faster and easier. Here are some of the top benefits of Neffy (epinephrine nasal spray):

User-Friendly, Needle-Free Epinephrine

One of Neffy’s most symbolic features and benefits is its needle-free delivery system. Many individuals at risk of anaphylaxis, especially children and those with needle phobias, hesitate to administer epinephrine through an auto-injector. This can pose severe threats of defective or delayed administration in times of emergency.

Neffy nasal spray eliminates this fear, offering individuals with severe allergies a more approachable way to administer life-saving medication during an anaphylactic reaction. Anaphylaxis emergencies can present very high-stress situations, making fast action and epinephrine administration crucial. Individuals can avoid the discomfort and complexities of epinephrine injections by simply spraying Neffy into one nostril.

Fast-Acting

Neffy epinephrine nasal spray delivers medication through the nasal membranes, which are highly vascular and rich in blood vessels. Intranasal administration of epinephrine allows it to be absorbed through the bloodstream rapidly. This fast-acting solution counteracts symptoms of anaphylaxis, such as breathing difficulties, swelling, airway constriction, and low blood pressure. Through clinical trials, the efficacy and speed of Neffy nasal spray are comparable, if not more effective, than traditional intramuscular auto-injections.

Portable and Lightweight

Neffy’s compact and lightweight design makes it easy to keep on hand at all times. Whether you’re carrying it in a purse, pocket, or bag, Neffy’s small size ensures users have easy access to their medication. Traditional epinephrine auto-injectors can be bulky and often too large to slip into a pocket or small purse.

Neffy’s portability is a significant advantage for the allergy community, as anaphylaxis can occur unexpectedly. With Neffy nasal spray, individuals at risk are more likely to have their medication with them at all times, mitigating the risk of delayed treatment during anaphylaxis.

Less Intimidating

Many people with severe allergies, particularly children, may be afraid or hesitant to use epinephrine auto-injectors. Individuals with a fear of needles find Neffy’s intranasal delivery to be a more convenient treatment option.

People at risk of type 1 hypersensitivity reactions may hesitate to use an injector during anaphylaxis, raising the risk of life-threatening consequences and fatal outcomes. Neffy offers a solution by eliminating that extra layer of stress and anxiety associated with epinephrine needle injectors in an anaphylactic emergency.

The Future of Anaphylaxis Treatment and Prevention

With over 33 million Americans having food allergies, more than half have experienced a severe reaction like anaphylaxis. Neffy is the first and only needle-free, intranasal epinephrine product approved by the FDA for individuals with severe allergies. This innovative solution is transforming the treatment of severe allergic reactions and anaphylaxis emergencies. The promising clinical results of Neffy and its user-friendly design could significantly increase the number of successful epinephrine administrations during anaphylaxis.

As Neffy becomes available and accessible, this intranasal epinephrine product may become the standard treatment for severe allergic reactions. Its affordability makes it more accessible to people with severe food allergies, latex allergies, and other allergies. With affordable epinephrine products, users won’t hesitate to use Neffy when experiencing an allergic reaction.

Neffy is available for as low as $25 with commercial insurance and specific health plans or a cash price of $199. This eliminates people having to weigh their options when determining whether or not their allergic reaction is “severe enough” to administer epinephrine. As the medical community embraces this new and innovative epinephrine product, we hope to see more effective treatment, management, and anaphylaxis awareness.

The KeepSmilin4Abbie Foundation’s ultimate mission is to raise awareness for anaphylaxis and individuals at risk. With over 15 million individuals at risk of life-threatening allergic reactions, the need for extensive research and awareness has never been more profound. Click here to help us in the fight to #stopanaphylaxis® and raise food allergy awareness!

 

 

References:

related Articles

  • Young adult student with a purple backpack and water bottle standing on sunlit campus steps under green trees
    Heading to College With a Severe Food Allergy: A Plan
    September 16, 2026

    A 504 plan does not follow a student to college, and the highest-risk years for fatal food reactions begin right as they leave home. Preparation covers campus dining, housing, roommates, and the emergency route.

  • Mother kneeling to eye level with her young daughter in a sunlit kitchen, a small green medical pouch on the counter
    Needle-Free Epinephrine Cleared for Younger Children
    September 9, 2026

    The FDA removed the age requirement from epinephrine nasal spray on March 26, 2026, so eligibility now rests on weight alone. Here is what that means for families of younger children, and what stays exactly the same in an emergency.

  • Small blank white skin patch on a young child's upper arm while a parent rests a hand on their shoulder
    Peanut Allergy Patch: How Viaskin Immunotherapy Works
    September 2, 2026

    Viaskin Peanut is an investigational skin patch that delivers small daily doses of peanut protein to desensitize children with peanut allergy, without swallowing anything or getting an injection. Phase 3 trial results show promising response rates, but the patch is not yet FDA approved and families still need a complete allergy action plan and epinephrine on hand.